Cargando…
Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching
Although many features of active transcriptional enhancers have been defined by genomic assays, we lack a clear understanding of the order of events leading to enhancer formation and activation as well as the dynamics of coregulator interactions within the enhancer complex. Here, we used selective l...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630019/ https://www.ncbi.nlm.nih.gov/pubmed/28887413 http://dx.doi.org/10.1101/gad.302182.117 |
_version_ | 1783269158907019264 |
---|---|
author | Murakami, Shino Nagari, Anusha Kraus, W. Lee |
author_facet | Murakami, Shino Nagari, Anusha Kraus, W. Lee |
author_sort | Murakami, Shino |
collection | PubMed |
description | Although many features of active transcriptional enhancers have been defined by genomic assays, we lack a clear understanding of the order of events leading to enhancer formation and activation as well as the dynamics of coregulator interactions within the enhancer complex. Here, we used selective loss- or gain-of-function mutants of estrogen receptor α (ERα) to define two distinct phases of ligand-dependent enhancer formation. In the first phase (0–20 min), p300 is recruited to ERα by Mediator as well as p300's acetylhistone-binding bromodomain to promote initial enhancer formation, which is not competent for sustained activation. In the second phase (20–45 min), p300 is recruited to ERα by steroid receptor coregulators (SRCs) for enhancer maturation and maintenance. Successful transition between these two phases (“coregulator switching”) is required for proper enhancer function. Failure to recruit p300 during either phase leads to abortive enhancer formation and a lack of target gene expression. Our results reveal an ordered and cooperative assembly of ERα enhancers requiring functional interplay among p300, Mediator, and SRCs, which has implications for hormone-dependent gene regulation in breast cancers. More broadly, our results demonstrate the unexpectedly dynamic nature of coregulator interactions within enhancer complexes, which are likely to be a defining feature of all enhancers. |
format | Online Article Text |
id | pubmed-5630019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cold Spring Harbor Laboratory Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56300192018-02-01 Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching Murakami, Shino Nagari, Anusha Kraus, W. Lee Genes Dev Research Paper Although many features of active transcriptional enhancers have been defined by genomic assays, we lack a clear understanding of the order of events leading to enhancer formation and activation as well as the dynamics of coregulator interactions within the enhancer complex. Here, we used selective loss- or gain-of-function mutants of estrogen receptor α (ERα) to define two distinct phases of ligand-dependent enhancer formation. In the first phase (0–20 min), p300 is recruited to ERα by Mediator as well as p300's acetylhistone-binding bromodomain to promote initial enhancer formation, which is not competent for sustained activation. In the second phase (20–45 min), p300 is recruited to ERα by steroid receptor coregulators (SRCs) for enhancer maturation and maintenance. Successful transition between these two phases (“coregulator switching”) is required for proper enhancer function. Failure to recruit p300 during either phase leads to abortive enhancer formation and a lack of target gene expression. Our results reveal an ordered and cooperative assembly of ERα enhancers requiring functional interplay among p300, Mediator, and SRCs, which has implications for hormone-dependent gene regulation in breast cancers. More broadly, our results demonstrate the unexpectedly dynamic nature of coregulator interactions within enhancer complexes, which are likely to be a defining feature of all enhancers. Cold Spring Harbor Laboratory Press 2017-08-01 /pmc/articles/PMC5630019/ /pubmed/28887413 http://dx.doi.org/10.1101/gad.302182.117 Text en © 2017 Murakami et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Paper Murakami, Shino Nagari, Anusha Kraus, W. Lee Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
title | Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
title_full | Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
title_fullStr | Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
title_full_unstemmed | Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
title_short | Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
title_sort | dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630019/ https://www.ncbi.nlm.nih.gov/pubmed/28887413 http://dx.doi.org/10.1101/gad.302182.117 |
work_keys_str_mv | AT murakamishino dynamicassemblyandactivationofestrogenreceptoraenhancersthroughcoregulatorswitching AT nagarianusha dynamicassemblyandactivationofestrogenreceptoraenhancersthroughcoregulatorswitching AT krauswlee dynamicassemblyandactivationofestrogenreceptoraenhancersthroughcoregulatorswitching |